Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Read about user experiences with no fee travel points cards. Gain insights to enhance your travel rewards journey!
17,260 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Bitcoin briefly peaked above $69k this week before pulling back toward $65k as equity markets turned lower and gold c...
NIO’s stock surged this week on improving fundamentals and a better-than-expected outlook. This article breaks down t...
Alix Earle launches Reale Actives, a skincare line built for acne-prone skin, marking her move from viral creator to ...
Analysts and investors are watching KLXE's Q1 2026 earnings closely. This article breaks down the transcript, interpr...
Tech stocks are leading the charge, lifting major indices to new highs. This guide breaks down the drivers, the bigge...
June 11 brought a surprising twist: Coupang’s privacy fine landed below feared levels, sending the stock higher and l...
Progressive is more than its ads. This article shows how underwriting profits interact with float income, and why ris...
SpaceX aims to put AI compute in orbit by 2028, a move that could reshape data centers. This article breaks down the ...
Cogent Communications stock crashed after a mixed quarter, delivering a revenue miss despite a narrower loss. This an...
OpenAI says shares Anthropic’s red lines on how the military can use AI, signaling a rare cross-firm consensus that c...
During a housing correction, buyers and homeowners rethink loan choices. This guide breaks down what we’re buying dur...